Akeso, Inc. announced that its B7-H3-targeting antibody-drug conjugate (ADC), AK157D1, has received Phase I trial clearance from China's National Medical...
-
-
Recent Updates
- 2026 World Green Trade Conference and Forum on AI and a Sustainable Future Held in Shanghai, China
- 2026 World Green Trade Conference and Forum on AI and a Sustainable Future Held in Shanghai, China
- China and Canada Extend Canola and Steel Market Access Deal to 2028
- Shanghai is ‘home’ to French musicals premiering in China
- Shanghai is ‘home’ to French musicals premiering in China
- Taiwan Casts Itself as Essential U.S. Tech Partner in China AI Race
- China’s largest import expo opens in Shanghai amid record trade imbalances
- China’s largest import expo opens in Shanghai amid record trade imbalances
- 9th China International Import Expo opens in Shanghai
- 9th China International Import Expo opens in Shanghai
Blogroll